[ORGANIZATION]
Bimekizumab
Featured in 1 tracked story · first seen
Situations
Biologic therapy analysis and new HS management guidelines
4 clusters · 5 sources · last updated
Latest: AAD and HSF issue first joint guidelines for hidradenitis suppurativa
Recent medical analyses have evaluated the comparative effectiveness and cost-efficiency of biologic therapies for moderate-to-severe hidradenitis suppurativa (HS), specifically focusing on adalimumab, secukinumab, and b